Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early prediction of residual disease after neoadjuvant chemoradiotherapy and cetuximab for locally advanced esophageal cancer using 18F-FDG PET-CT imaging: a prospective cohort study.
Brenner B, Kundel Y, Cohen Z, Brand H, Gordon N, Sulkes A, Morgenstern S, Menasherov N, Kashtan H, Groshar D, Domachevsky L, Bernstine H. Brenner B, et al. Among authors: menasherov n. J Gastrointest Oncol. 2022 Dec;13(6):2721-2735. doi: 10.21037/jgo-22-352. J Gastrointest Oncol. 2022. PMID: 36636052 Free PMC article.
The addition of cetuximab to preoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma is associated with high rate of long term survival: Mature results from a prospective phase Ib/II trial.
Brenner B, Purim O, Gordon N, Goshen-Lago T, Idelevich E, Kashtan H, Menasherov N, Fenig E, Sulkes A, Kundel Y. Brenner B, et al. Among authors: menasherov n. Radiother Oncol. 2019 May;134:74-80. doi: 10.1016/j.radonc.2019.01.013. Epub 2019 Feb 4. Radiother Oncol. 2019. PMID: 31005227 Clinical Trial.
12 results